Teva Pharmaceuticals USA, Inc. recalls Metoprolol Tartrate Tablets USP 50 mg, 1000 count bottle
Hinjwadi, Pune, India, Manufa… beginning May 16, 2012, in a drug recall whose distribution included Ohio.
Teva Pharmaceuticals USA, Inc. began a drug recall on May 16, 2012 whose reported distribution included Ohio. FDA
What the record shows
recalled Metoprolol Tartrate Tablets USP 50 mg, 1000 count bottle, Rx only, Manufactured in india By: Emcure Pharmaceuticals LTD. The stated reason: Tablet Thickness: Potential for some tablets not conforming to weight specifications (under and over weight) FDA graded it Class II — use may cause temporary or medically reversible health consequences. Quantity affected: 2,268 bottles. The recall is listed as terminated. FDA
Context
By the numbers
- Date of record: May 16, 2012 FDA
- Recall number: D-1409-2012 FDA
- Recalls in this action: 1 FDA
- Recalling firm: Teva Pharmaceuticals USA, Inc. FDA
- Product: Metoprolol Tartrate Tablets USP 50 mg, 1000 count bottle, Rx only, Manufactured in india By: Emcure Pharmaceuticals… FDA
- Reason for recall: Tablet Thickness: Potential for some tablets not conforming to weight specifications (under and over weight) FDA
Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA
Sources
The source filing
| Recall number | D-1409-2012 |
|---|---|
| Recalls in this action | 1 |
| Recalling firm | Teva Pharmaceuticals USA, Inc. |
| Product | Metoprolol Tartrate Tablets USP 50 mg, 1000 count bottle, Rx only, Manufactured in india By: Emcure Pharmaceuticals LTD. Hinjwadi, Pune, India, Manufactured for TEVA Phamaceuticals USA, Sellersville, PA 18960, NDC 0093-0733-10 |
| Reason for recall | Tablet Thickness: Potential for some tablets not conforming to weight specifications (under and over weight) |
| Classification | Class II — use may cause temporary or medically reversible health consequences |
| Recall type | drug |
| Quantity | 2,268 bottles |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm initiated |
| Initiated | 20120516 |
| Reported | 20120711 |
| Distribution | Ohio |
| Firm location | Sellersville, PA, United States |
Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.